Nothing Special   »   [go: up one dir, main page]

AU2127400A - A pharmaceutical composition for the administration of water-insoluble pharmaceutically active substances and process for preparation thereof - Google Patents

A pharmaceutical composition for the administration of water-insoluble pharmaceutically active substances and process for preparation thereof

Info

Publication number
AU2127400A
AU2127400A AU21274/00A AU2127400A AU2127400A AU 2127400 A AU2127400 A AU 2127400A AU 21274/00 A AU21274/00 A AU 21274/00A AU 2127400 A AU2127400 A AU 2127400A AU 2127400 A AU2127400 A AU 2127400A
Authority
AU
Australia
Prior art keywords
administration
preparation
water
pharmaceutical composition
active substances
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU21274/00A
Inventor
Amar Lulla
Geena Malhotra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cipla Ltd
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Publication of AU2127400A publication Critical patent/AU2127400A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13Cyclosporins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AU21274/00A 1999-11-02 1999-11-02 A pharmaceutical composition for the administration of water-insoluble pharmaceutically active substances and process for preparation thereof Abandoned AU2127400A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN1999/000062 WO2001032143A1 (en) 1999-11-02 1999-11-02 A pharmaceutical composition for the administration of water-insoluble pharmaceutically active substances and a process for preparation thereof

Publications (1)

Publication Number Publication Date
AU2127400A true AU2127400A (en) 2001-05-14

Family

ID=11076677

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21274/00A Abandoned AU2127400A (en) 1999-11-02 1999-11-02 A pharmaceutical composition for the administration of water-insoluble pharmaceutically active substances and process for preparation thereof

Country Status (3)

Country Link
AR (1) AR026101A1 (en)
AU (1) AU2127400A (en)
WO (1) WO2001032143A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100425755B1 (en) * 2001-08-27 2004-04-03 주식회사 원진신약 Compositions containing itraconazole and their preparation methods
US20050232974A1 (en) * 2004-04-19 2005-10-20 Gore Makarand P System and a method for pharmaceutical dosage preparation using jettable microemulsions
US7202209B2 (en) * 2005-07-13 2007-04-10 Allergan, Inc. Cyclosporin compositions
US7297679B2 (en) * 2005-07-13 2007-11-20 Allergan, Inc. Cyclosporin compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8903804D0 (en) * 1989-02-20 1989-04-05 Sandoz Ltd Improvements in or relating to organic compounds
DE68900991D1 (en) * 1988-01-29 1992-04-23 Sankyo Co CYCLOSPORIN COMPOSITIONS.
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds
EP0760237A1 (en) * 1995-08-30 1997-03-05 Cipla Limited Oil-in-water microemulsions
WO1998040051A1 (en) * 1997-03-12 1998-09-17 Abbott Laboratories Lipophilic binary systems for the administration of lipophilic compounds
ID25908A (en) * 1998-03-06 2000-11-09 Novartis Ag EMULSION PRACTONCENTRATES CONTAINING CYCLOSPORINE OR MACROLIDES

Also Published As

Publication number Publication date
WO2001032143A1 (en) 2001-05-10
AR026101A1 (en) 2003-01-29

Similar Documents

Publication Publication Date Title
CA2258095A1 (en) Tetrahydrolipstatin containing compositions
HUP0203312A3 (en) Pharmaceutically active sulfonamide derivatives, process for their preparation, and pharmaceutical compositions and their use
AU2002216701A1 (en) Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
AU4334700A (en) Pharmaceutical dosage form for pulsatile delivery of methylphenidate
AU2879100A (en) Formulation and system for intra-oral delivery of pharmaceutical agents
HUP0004383A3 (en) Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient
AU5936400A (en) Formulations comprising dehydrated particles of pharmaceutical agents and process for preparing the same
AU2001232337A1 (en) Pharmaceutical composition, reagent and method for intracerebral delivery of pharmaceutically active ingredient or labeling substance
AU7305594A (en) Physiologically active substance-prolonged releasing-type pharmaceutical preparation
AU3076700A (en) 2h-phthalazin-1-one derivatives and drugs comprising these derivatives as the active ingredient
HUP0203451A3 (en) Pharmaceutical compositions of anti-tubercular drugs and process for their preparation
CA2315261A1 (en) Oral pharmaceutical extended release dosage form
HUP0301325A3 (en) Stabilized pharmaceutically effective composition and pharmaceutical composition comprising the same and process for preparation the composition
HUP0303891A3 (en) Pharmaceutically active piridine derivatives, process for their preparation and pharmaceutical compositions containing them
AU2513900A (en) Drug dosage unit for buccal administration of steroidal active agents
AU4681200A (en) A pharmaceutical composition of concentrates for microemulsion and self-emulsifying drug delivery system
HUP0302319A3 (en) Pharmaceutical composition for oral administration of active ingredient
CA2311450A1 (en) Pharmaceutical aerosol compositions
HUP0104687A2 (en) Methods for preparing coated drug particles and pharmaceutical formulations thereof
AU1307399A (en) Stabilized, dry pharmaceutical compositions for drug delivery and methods of preparing same
AU7032500A (en) A process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine
HUP0203060A3 (en) Sustained release complex of a peptide, process for its preparation and pharmaceutical composition containing the same
GB0029936D0 (en) A pharmaceutical formulation suitable for the treatment of hepititis B, hepititis C and other viral infections of the liver and a process for its preparation
IL145559A0 (en) Tolperison-containing pharmaceutical preparation for oral administration
AU777185C (en) Pharmaceutical form of administration for peptides, methods for its production and use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase